ISSN: 2167-0889
Liver Fibrosis Conventional and Molecular Imaging Diagnosis Update
Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma
View More »
Journal of Liver received 597 citations as per Google Scholar report
Editorial Note
Excessive Alcohol Consumption Can Harm Liver
Editorial
Liver Cirrhosis: Causes and Preventive Measures
An Overview on Non-alcoholic Fatty Liver Disease
A Brief Note on Hepatocellular carcinoma
Clinical Symptoms Associated with Hepatitis C
Editor’s Note
Past Conference Report of 23rd World Congress on Toxicology and Pharmacology | Webinar
Conference Announcement of 23rd World Congress on Toxicology and Pharmacology | Webinar
Editor Note
23rd World Congress on Toxicology and Pharmacology | May 26-27, 2021 Webinar | THEME: Probing novel facts in Toxicology and Pharmacology
Market Analysis of 23rd World Congress on Toxicology and Pharmacology | Webinar
Academic Awards of 23rd World Congress on Toxicology and Pharmacology | Webinar
Commentary
Detection of Liver Steatosis by Using MR Imaging Techniques
DOI: 10.35248/2167-0889.22.11.125
Wilson’s Disease- Recent Advancements
DOI: 10.35248/2167-0889.22.11.127
Perspective
Hepatic Biliary Tract Symptoms of Sickle Cell Anemia
DOI: 10.35248/2167-0889.22.11.129
Hepatitis: Causes and Prevention
DOI: 10.35248/2167-0889.22.11.126
Inflammatory Glucose Restriction in Liver Induces Antibiotic Resistance to
DOI: 10.35248/2167-0889.22.11.128
Opinion Article
Risk Factors Associated With Liver Damage after Weight Loss Surgery
DOI: 10.35248/ 2329-6925.22.11.131
Short Communication
Acute Liver Failure Due to Liver Lenticular Degeneration
DOI: 10.35248/ 2329-6925.11.130
Effect of COVID 19 on Liver Abnormalities
DOI: 10.35248/ 2329-6925.22.11.132
Pharmacotherapy Interference for the Treatment of Liver Fibrosis
DOI: 10.35248/ 2329-6925.22.11.133
Biliary Atresia: Symptoms and Therapy
DOI: 10.35248/ 2329-6925.22.11.134
Persistence of Fibrogenic Signals in DAA-Treated HCV Patients Inspite of SVR
DOI: 10.35248/ 2329-6925.22.11.135
Anatomical Description and Functions of Liver in Human Body
DOI: 10.35248/2329-6925.22.11.137
Viral Hepatitis C Epidemiology in Rural Areas
DOI: 10.35248/2329-6925.22.11.138
The Management of Impairment in Patients with Liver Cirrhosis
DOI: 10.35248/2329-6925.22.11.139
Research Article
A Retrospective Study into Etiology, Clinical Outcomes and Prognostic Factors of Severe Acute Liver Injury in Hong Kong
DOI: 10.35248/2329-6925.22.11.136
Mini Review
Referral of Intermediate and High-Risk Non-Alcoholic Fatty Liver Disease Patients to Hepatology Based on Noninvasive Tests
DOI: 10.35248/2167-0889.11.140
Role of Combined Metabolic Stimulators in Reducing the Liver Fat
DOI: 10.35248/2167-0889.11.141
Impact of Preoperative Chemotherapy on Liver Regeneration in Patients with Colorectal Liver Metastases
DOI: 10.35248/2167-0889.11.142
Infection Rates of the Hepatitis B and C Virus in Potential Blood Donors
DOI: 10.35248/2167-0889.11.143
Association of Bacterial Infections with Pediatric Liver Transplantation
DOI: 10.35248/2167-0889.11.144
Association of liver fibrosis with impaired bone mineralization
DOI: 10.35248/2167-0889.22.11.145
Fatty Liver Disease and Environmental Exposure to Cooking Oil Fume
DOI: 10.35248/2167-0889.22.11.146
Relationship between Osteoarthritis and Non-Alcoholic Fatty Liver Disease
DOI: 10.35248/2167-0889.22.11.147
Energy Malnutrition Indicators in Chronic Liver Disease Patients
DOI: 10.35248/2167-0889.22.11.148
Role of Thyroid hormone in hyperthyroidism patients suffering with non-alcoholic fatty liver disease
DOI: 10.35248/2167-0889.22.11.149
Unsaturated Fatty Acids and their Effects on Non-alcoholic Fatty Liver Disease
DOI: 10.35248/2167-0889.22.11.150
Commentry
The Role of Non-Alcoholic Fatty Liver Cirrhosis as a Risk Factor for the Severity of Acute Cholangitis
DOI: 10.35248/2167-0889.22.11.151
Occurrence of Hepatic Steatosis and Fatty Liver Disease in Breast Cancer Survivors
DOI: 10.35248/2167-0889.22.11.152
Rapamycin and its Function in Aging Liver Processes
DOI: 10.35248/2167-0889.22.11.153
Age-Related Non-Alcoholic Patients with Fatty Liver Disease: Disease Progression-Related Markers
DOI: 10.35248/2167-0889.22.11.154